CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Sources of Typical Errors in Next-Generation Sequencing

Sources of Typical Errors in...

Applications of NGS technology

Applications of NGS technology

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Pharmaceutical Tablet Coating - Past, Present and Future

Pharmaceutical Tablet Coating - Past,...

Dynamic Commercial Aspects  of Life Sciences

Dynamic Commercial Aspects of Life...

Achieving trial master file quality, timeliness and completeness

Achieving trial master file quality,...

Sources of Typical Errors in Next-Generation Sequencing

Sources of Typical Errors in...

Applications of NGS technology

Applications of NGS technology

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Pharmaceutical Tablet Coating - Past, Present and Future

Pharmaceutical Tablet Coating - Past,...

Dynamic Commercial Aspects  of Life Sciences

Dynamic Commercial Aspects of Life...

Achieving trial master file quality, timeliness and completeness

Achieving trial master file quality,...

Clinical Applications in Next-Generation Sequencing

Life Sciences Review | Monday, January 02, 2023
Tweet

Clinical applications of NGS optimizes healthcare in cancer treatment, vaccine development, and understanding allergies.


FREMONT, CA: Scientists could read humans' entire genetic blueprint through traditional DNA sequencing methods. Emerging sequencing solutions are opening new doors to various clinical applications. Traditional DNA sequencing techniques could have been more time-consuming and efficient. Although the HGP achieved groundbreaking results, new technologies, such as next-generation sequencing, have since emerged. Sequencing DNA using a modern and rapid method can read large volumes of DNA sequences simultaneously.


Next-generation sequencing (NGS) has greatly improved DNA sequencing accuracy by minimizing errors. The NGS revolutionized healthcare by lowering sequencing costs and reducing diagnosis times. Currently, it takes less than 6 hours to sequence the human genome.


The following applications leverage NGS to streamline healthcare.


Cancer Treatment: Medical professionals have always found cancer challenging because each type of cancer is different, and even a type of cancer may behave differently in different individuals.


DNA sequencing can identify unique errors in DNA that cause cancer. It is now possible for scientists to use NGS to analyze the genomes of individual patients and identify the DNA errors specific to each individual. Doctors can then design customized treatments for each patient based on this information. There are cases in which two similarly afflicted patients will respond differently to the same treatment-a treatment that cures one will fail to cure the other. NGS can detect small changes in the genomes of two individuals, which can be used to personalize therapy for individual patients.


Vaccines: During the COVID-19 pandemic, sequencing has been tremendously helpful for investigating the origin of the SARS-CoV-2 virus and developing vaccines. SARS-CoV2 was sequenced using NGS, enabling researchers to understand its genetic characteristics, such as the spike protein, which threatens the immune system. As viruses evolve, so do their variants. An NGS analysis was also useful when tracking new variants.


Allergies: Genomic sequencing helps scientists determine a person's likelihood of having an allergy to gluten or lactose intolerance based on their genome. The sequence of a person's DNA may affect their chance of developing allergies.


Weekly Brief

loading
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/clinical-applications-in-nextgeneration-sequencing--nwid-1068.html